Eric vd helm

Eric vd helm

Company: SNIPR Biome

Job title: vp


The Potential of Using CRISPR Technology for Microbial Gene Therapy 2:30 pm

Discovering SNIPR, a pioneering use of CRISPR/Cas technology for microbial gene therapy  Examining SNIPR001, the leading program, and its aims at prevention of fluoroquinolone resistant E. coli bloodstream infections in hematological cancer patients Review how SNIPR001 is progressing in clinical development with an IND cleared in and FDA Fast Track Designation granted Hear details of…Read more

day: Day Two Track A PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.